ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00350051
Recruitment Status : Completed
First Posted : July 10, 2006
Last Update Posted : December 4, 2014
Information provided by (Responsible Party):